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 Neuronal vacuolar-type H+-ATPase (V-ATPase) is an ATP-dependent proton pump that 
functions to acidify intracellular organelles such as lysosomes and synaptic vesicles, creating a 
proton gradient by which neurotransmitters can enter the vesicle through proton-coupled 
neurotransmitter transporters, a crucial step in neurotransmission (Moriyama, Maeda, & Futai, 
1992). It is composed of two reversible domains, the integral V0 that allows proton translocation 
and catalytic peripheral V1 that is responsible for ATP hydrolysis. The V-ATPase regulates its 
activity through a process called reversible disassembly. When the V0 and V1 domains assemble, 
V-ATPase is activated and allows the influx of protons. When the domains disassemble, V-
ATPase is inactivated, and proton transport does not occur (Beltran & Nelson, 1992).  
V-ATPase assembly was previously demonstrated to be regulated by glucose in yeast 
(Kane, 1995) and some mammalian cells (Toei, Saum, & Forgac, 2010), but whether and how 
glucose regulates neuronal V-ATPase is unclear. This study investigates the effect of 
bioenergetic substrates on neuronal V-ATPase assembly. Neuro2a (N2a) cells were 
differentiated for 96 hours, glucose-deprived overnight, and then treated with substrates such as 
glucose, beta-hydroxybutyrate, sodium pyruvate, creatine phosphate, and creatine monohydrate 
for 20 minutes prior to cell lysate preparation. To study V-ATPase assembly, assembled V-
ATPase were captured through co-immunoprecipitation. Equal amounts of cell lysate were 
incubated with V1 antibody-coupled resin. Immunoblotting was then performed on the eluate to 
detect the V1 and V0 domains. The density of the bands was quantified and the ratio of V0 and V1 
domains was used to determine V0/ V1 assembly.  
The results demonstrate changes in glucose availability (deprivation/stimulation) did not 
impact V-ATPase assembly in differentiated N2a cells. Furthermore, the results show other 
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bioenergetic substrates (pyruvate, beta-hydroxybutyrate, and creatine molecules) did not induce 
changes in neuronal V-ATPase assembly. Our results did not support the well-documented role 
of glucose regulation of V-ATPase assembly demonstrated in previous studies conducted in 
yeast and mammalian cells.  
Several pitfalls of this study may have contributed to the negative results. The glucose 
concentration for stimulation and incubation time for glucose-deprivation may not have been 
optimal for differentiated N2a cells; further investigation will be needed to optimize these 
conditions. The glucose concentration used for stimulation after overnight glucose-deprivation 
did not exceed the physiological glucose concentration; higher concentrations of glucose should 
be tested. Previous studies had various incubation times for glucose-deprivation that could be 
experimentally optimized. Furthermore, the experiments could be replicated in other neuronal 
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Chapter 1: Introduction 
1.1. Vacuolar-type H+ ATPases 
1.1.1. Structure and Function  
V-ATPase Structure 
The Vacuolar-type H+ ATPase, or V-ATPase, is a multifaceted ATP-dependent proton 
pump (Gluck & Caldwell, 1987; Sun-Wada & Wada, 2015). It has two reversible domains, the 
membrane bound V0 and cytosolic V1 (Parra & Kane, 1998) (Nishi & Forgac, 2002). The 
membrane bound V0 domain is made up of 5 subunits denoted by the lowercase letters a, c, c’’, 
d, and e (Sagermann, Stevens, & Matthews, 2001). Subunit a has four isoforms, a1 to a4 
(Kawasaki-Nishi, Nishi, & Forgac, 2001b). Subunit a1-a3 are expressed ubiquitously whereas a4 
is expressed in renal cells, heart, lung, skeletal muscle, and testis. Subunit a1 is expressed mainly 
in neurons, a2 in the liver and kidneys, and a3 in osteoclasts. The V0 domain in yeast includes an 
additional subunit c’ and mammals have an additional Ac45 (Jansen et al., 2010). The catalytic 
V1 domain contains 8 subunits denoted by the uppercase letters A-H. Subunits B, C, E, and G 
each have specific isoforms.  
Similar to other members of the ATPase, the V-ATPase functions by a rotary mechanism 
(Murata, Yamato, Kakinuma, Leslie, & Walker, 2005) and many structural aspects are 
conserved. According to Beyenbach, the accepted functional model of the V-ATPase states that 
it is composed of two parts, a stator and rotor (Boekema, Ubbink-Kok, Lolkema, Brisson, & 
Konings, 1997) (Imamura et al., 2003). The rotor is made of subunit D, F, and c-ring, whereas 




Figure 1. V-ATPase Structure 
                                                                                                                                                                                                   









V1 domain of V-ATPase 
The cytosolic V1 domain consists of three subdomains – the A3B3 head, central 
rotational stalk, and peripheral stalk (MacLeod, Vasilyeva, Baleja, & Forgac, 1998; Maher et al., 
2009). The A3B3 head is composed of three alternating subunits of A and B in a ring structure 
(Forgac, 2007).The central rotational stalk is made of subunit D, F, and d (Muench et al., 2009) 
(Benlekbir, Bueler, & Rubinstein, 2012; Z. Zhang et al., 2008). Finally, the peripheral stalk 
consists of subunit C, E, G, and H. In the A3B3 head, the A and B subunits contain ATP 
hydrolytic sites. Together, the central rotational stalk and fixed peripheral stalk serve to connect 
the V0 and V1 domains. The stator peripheral stalk stabilizes and prevents the rotation of the 
A3B3 head, especially through the actin-binding function of subunit C (Forgac, 2007). Subunit 
H, in the peripheral stalk, was found to be vital in the inhibition of free V1 by its’ interaction with 
subunit F to inhibit ATP hydrolysis (Jefferies & Forgac, 2008). Although Free V1 with subunit H 
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was found to hydrolyze Ca-ATP, only free V1 without subunit H could hydrolyze Mg-ATP 
(Parra, Keenan, & Kane, 2000). 
 
V0 Domain of V-ATPase 
The membrane bound V0 domain is involved in proton transport and is composed of 
subunits a, d, e, and c-ring, which is made of hydrophobic c subunits in the structure of a ring. 
Subunit a creates two hemichannels for proton entry and has a buried arginine residue that is 
crucial in proton translocation (Wilkens & Forgac, 2001). The d subunit is a component of the 
central rotational stalk and serves to connect the V0 and V1 domains. The role of subunit e is 















Function of V-ATPase 
The main function of the V-ATPase is to acidify intracellular membrane-enclosed 
compartments (Parra & Kane, 1998), such as lysosomes, endosomes, vacuoles, secretory 
vesicles, through ATP hydrolysis and to create a proton gradient to facilitate proton-coupled 
transport of solutes across the membrane (Moriyama et al., 1992; Parsons, 2000) (Stevens & 
Forgac, 1997). The membrane bound V0 domain functions to translocate protons whereas the 
cytosolic V1 domain plays a role in ATP hydrolysis. The V-ATPase is involved in a multitude of 
physiological processes such as endocytosis, membrane trafficking, and the coupled uptake of 
neurotransmitters (Lafourcade, Sobo, Kieffer-Jaquinod, Garin, & van der Goot, 2008; O. Muller, 
Neumann, Bayer, & Mayer, 2003). Abnormal activity in the V-ATPase has been associated with 
viral infections, diabetes, cancer, osteoporosis, and neurodegenerative diseases (Liu et al., 2017; 
K. H. Muller et al., 2011; Nixon, 2013; Sennoune et al., 2004). Due to this, the V-ATPase is a 
potential drug target for many diseases. Neuronal V-ATPase accounts for approximately 8% of 
the total protein resided on the membrane of synaptic vesicles, making it vital for 
neurotransmitter release and synaptic transmission (Takamori et al., 2006).  
 
Mechanism of V-ATPase 
The fundamental model of the rotary mechanism is constructed of two proton 
hemichannels, a proton binding site on each subunit on the c-ring, and ATP hydrolysis driven c-
ring rotation (Sambongi et al., 1999) (Forgac, 2007). The coupling ratio for V-ATPase activity is 
2 - 4 protons transported per ATP consumed (Kawasaki-Nishi et al., 2001b) (Tomashek & 
Brusilow, 2000). When the V0 and V1 domains are assembled, the V-ATPase is activated, and 
proton translocation is allowed. First, cytoplasmic protons enter through the inner H+ 
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hemichannel formed by subunit a and each protonate one c subunit on the c-ring, specifically by 
binding a glutamic acid residue. Then ATP hydrolysis, at the catalytic A3B3 head, causes a 
conformation change that drives rotation of the central rotational stalk, leading to a 360° c-ring 
rotation (Meier, Polzer, Diederichs, Welte, & Dimroth, 2005). Rotation of the c-ring allows 
protonated glutamic acid residues to interact with an arginine residue in the outer hemi-channel 
and become stabilized (Kawasaki-Nishi, Nishi, & Forgac, 2001a). After stabilization, protons 
then unbind from the c-ring and exit through the outer hemi-channel of subunit a. The proton 
then enters the intracellular membrane and acidifies the lumen (Nishi & Forgac, 2002). 
Concanamycin a, a specific inhibitor of V-ATPase, binds to subunit c of the V0 domain to 
prevent c-ring rotation and subsequently ATP hydrolysis. Interestingly, concanamycin a binding 
prevents V-ATPase from disassembling but has no effect on its’ reassembly (Parra & Kane, 
1998). 
 
1.1.1.1. Lysosomal Activity  
 The function of lysosomal V-ATPase has been studied extensively in yeast and 
mammalian cells to a lesser extent. Lysosomes are organelles that contain degradative enzymes 
known as hydrolases and function in intracellular digestion (de Duve, 2005; De Duve & 
Wattiaux, 1966). Therefore, V-ATPase plays a crucial role in the proper functioning of 
lysosomes by acidifying the lysosomal lumen to an optimal pH of 4.5-5 (Pillay, Elliott, & 
Dennison, 2002). The acidification of lysosomes is a necessity for degradative enzyme activity 
and the export of degradation products by coupled transporters (Rahman, Ramos-Espiritu, 
Milner, Buck, & Levin, 2016) (Mellman, Fuchs, & Helenius, 1986) (Sagne et al., 2001). 
Lysosomal V-ATPase participate in bone resorption, transportation of acid hydrolases, and 
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tumor growth. The dysfunction of lysosomal acidification leads to the pathogenesis of lysosomal 
storage disorders (LSDs), Osteoporosis, and neurodegenerative diseases such as Alzheimer’s and 
Parkinson’s disease (Bagh et al., 2017) (Futerman & van Meer, 2004) (Nixon, 2013; Saftig & 
Klumperman, 2009). However, the mechanisms surrounding dysfunctional lysosomal 
acidification for neurodegenerative diseases are unclear.  
Osteoclasts are multinucleated cells involved in bone reabsorption by secreting digestive 
enzymes to dissolve bone tissue (Teitelbaum, 2007). A mature osteoclast can form a lacunae 
between the ruffled border membrane and bone surface (Ochotny et al., 2011). Subunit a3 of the 
V-ATPase is expressed in osteoclasts and provides an acidic pH of the lacunae that leads to 
mineral solubilization and the hydrolysis of bone matrix (Toyomura et al., 2003). The degraded 
matrix is then transported into luminal acidic vesicles to the secretory domain (Boyle, Simonet, 
& Lacey, 2003). Mutations in subunit a3 can cause impaired proton translocation, bone 
resorption, and an increase in bone density that can lead to hyper or hypoactivity of osteoclasts 
(Ochotny et al., 2011). Hyperactivity of osteoclasts is associated with osteoporosis and 
periodontal disease (Teitelbaum, 2000). Osteoporosis develops as the result of genetic defects in 
osteoclast V-ATPase, 50% of patients with autosomal recessive osteoporosis have a mutation in 
subunit a3 (Frattini et al., 2000). Conversely, hypoactivity of osteoclasts leads to an increase of 
bone mass and osteopetrosis.  
 
1.1.1.2 Synaptic Transmission 
 The V-ATPase is vital in the storage of neurotransmitters in synaptic vesicles (SV) and 
subsequently in neuronal transmission. Neuronal V-ATPase allows the transport of protons into 
synaptic vesicles through ATP hydrolysis, creating a proton gradient and membrane potential. 
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The accumulation of protons creates an electrochemical gradient that drives the uptake of 
neurotransmitters into synaptic vesicles by a neurotransmitter transporter (Moriyama et al., 
1992). The inhibition by concanamycin a, specific V-ATPase inhibitor, decreased the uptake of 
neurotransmitters, providing evidence for the uptake of neurotransmitters for V-ATPase. V-
ATPase makes up 8% of the total protein in synaptic vesicles (Takamori et al., 2006). SV are 
equipped with monoamine, acetylcholine, anionic glutamate, GABA, and zwitterionic glycine 
transporters.  
 Prior to neurotransmission, synaptotagmin responds to a calcium influx by docking the 
filled synaptic vesicle to an active site on the presynaptic membrane before fusion to release its 
neurotransmitters into the synaptic cleft (Morel, Dunant, & Israel, 2001). This process called 
priming, utilizes the SNARE (soluble N-ethylmaleimide sensitive factor attachment protein 
receptors) protein complex. The SNARE complex is composed of two parts, the vesicle-SNARE 
(v-SNARE) and target-SNARE (t-SNARE). The v-SNARE is present in synaptic vesicles and 
expressed by synaptobrevin and VAMP2. The t-SNARE is expressed by syntaxin1 and SNAP-25 
on the presynaptic membrane and functions to stabilize and guide v-SNARE’s to bind and form 
the SNARE complex for membrane fusion. The c subunit of V0 (referred to as V0c) of the V-
ATPase interacts with v-SNARE to form a fusion pore that opens and expands to diffuse 
neurotransmitters into the synaptic cleft (Di Giovanni et al., 2010; El Far & Seagar, 2011). In a 
“kiss and run” scenario, the fusion pore may close after a brief opening. Additionally, subunit a1 
of the V0 domain (V0a1) was discovered in synaptic terminals and found to interact with v-
SNARE (Morel, Dedieu, & Philippe, 2003). V0a1 is a vital regulator of synaptic vesicle fusion 
that acts downstream of SNARE-complex priming (Hiesinger et al., 2005). These studies 
implicate that the V-ATPase not only plays a role in acidifying synaptic vesicles for the uptake 
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of neurotransmitters, but they also have a vital role in synaptic vesicle fusion in the release of 














1.1.1.3 Tumor cell invasion 
Plasma membrane V-ATPase have been actively studied for its role in the metastasis of tumor 
cells (Sennoune et al., 2004) (Hinton et al., 2009). In this context, plasma membrane V-ATPases 
provide alkaline intracellular environment and an acidic extracellular environment. The alkaline 
intracellular environment is predicted to allow tumor growth, whereas the acidic extracellular 
environment supports invasion (Sennoune & Martinez-Zaguilan, 2007). Subunit a2 isoform of 
V-ATPase is expressed in cancer cells. A defective a2 in tumor cells leads to an alteration in 
macrophage numbers and affects the growth of tumors (Katara et al., 2016). A strong indicator 
for cancer is the increased use of glycolysis and dependence on V-ATPase to create the alkaline 
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intracellular pH and acidic extracellular pH for tumor cell proliferation (Torigoe et al., 2002). 
The increased use of glycolysis for cellular bioenergetics is activated by the alkaline intracellular 
pH and inhibits oxidative phosphorylation (Alfarouk et al., 2014). Conversely, an acidic 
intracellular pH drives oxidative phosphorylation. The transformation from preference for 
oxidative phosphorylation to glycolysis is known as the Warburg effect (Liberti & Locasale, 
2016). 
 
1.1.2 Regulatory mechanisms 
The V-ATPase responds to a multitude of factors, the most well studied is reversible 
disassembly. Disassembly of the V-ATPase leads to the V1 domain and subunit C to disassociate 
from the membrane bound V0 domain (Kane, 1995). Free V1 domains cannot hydrolyze the ATP 
(Graf, Harvey, & Wieczorek, 1996) and free V0 domains cannot allow the passage of protons 
(Beltran & Nelson, 1992), which renders the V-ATPase inactive. For disassembly to occur, the 
V-ATPase must be catalytically active, as there are V-ATPase that are inactive and do not 
disassemble (Parra & Kane, 1998). Microtubules are also involved in the disassembly of V-
ATPase (Xu & Forgac, 2001). The disassembly of domains was first confirmed in yeast, glucose 
deprivation for 5 min was able to trigger the disassembly of 70% of the complexes (Kane, 1995). 
The readdition of glucose reversed disassembly and allowed the complexes to reassemble. V-
ATPase reassembly factors are species specific but typically include the RAVE (Regulator of 
ATPases of Vacuoles and Endosomes), rabconnectin, glycolytic enzymes, and several signaling 
pathways. V-ATPase reversible disassembly is a regulatory mechanism crucial to the 




The regulatory mechanisms of V-ATPase reversible disassembly are not completely 
understood. For a long time, V-ATPase reversible disassembly was thought to be universally 
regulated by glucose (Sautin, Lu, Gaugler, Zhang, & Gluck, 2005). Conversely, the results of a 
yeast cell study (Diakov & Kane, 2010) showed V-ATPase activity actually increased in glucose 
deprived and high external pH conditions. The authors concluded that the increase in external pH 
somehow stabilized V-ATPase complexes by suppressing disassembly in glucose deprived 
conditions and allowed the V-ATPase to be more active and less likely to disassembly. The 
increased external pH and glucose-deprived conditions were thought to increase V-ATPase 
activity as a mechanism to protect intracellular compartments from being acidified from the 
export of cytosolic protons outside the cell by Pma1 (Diakov & Kane, 2010). Additionally, V-
ATPase activity was also found to increase in glucose-deprived mammalian cells (McGuire & 
Forgac, 2018). These studies emphasize how much there is still to learn about the regulation of 
V-ATPase. 
 
1.1.2.1 Glycolytic regulation 
V-ATPase regulation by glucose is the most widely studied regulatory mechanism. 
Glycolysis is important in the production of ATP and in promoting V-ATPase assembly. The 
generated ATP stimulate proton-pumping for the acidification of intracellular compartments. V-
ATPase assembly with glucose stimulation was observed in yeast and mammalian cells (Kane, 
1995; Sautin et al., 2005). Glucose addition leads to the assembly of V-ATPase and its 
activation. Disassembly by glucose deprivation inactivates the V-ATPase. Furthermore, V-
ATPase disassembly functions to maintain pH and conserve ATP during glucose starvation. V-
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ATPase assembly functions to acidify the intracellular lumen as well as ameliorate cytosolic 
acidification from glycolysis (Parra, Chan, & Chen, 2014).  
 
Assembly Factors 
In yeast cells, V-ATPase is thought to assemble with the help of RAVE and glycolytic 
enzymes such as aldolase and phosphofructokinase-1 (PFK-1). RAVE is a chaperone protein 
with three components, Skp1p protein and subunits Rav1p and Rav2p. RAVE binds free V1 and 
subunit C to stabilize the free V1 for reassembly (Seol, Shevchenko, Shevchenko, & Deshaies, 
2001). Interestingly, RAVE only binds Vph1p, a vacuolar subunit ‘a’ isoform, from vacuoles and 
not stv1p, a Golgi and endosomal subunit ‘a’ isoform. Also, RAVE aids in assembly 
independently from glucose (Smardon, Tarsio, & Kane, 2002). PFK-1 is a rate-limiting enzyme 
in glycolysis that functions as a glucose sensor. PFK-1 functions to regulate V-ATPase proton 
transport with the fluctuation of glycolysis (Parra et al., 2014). PFK-1 signals RAVE in the 
presence of glucose which triggers RAVE to assemble the V-ATPase. Aldolase binds subunits E, 
B, and a to stabilize the V-ATPase (Lu, Sautin, Holliday, & Gluck, 2004). 
 
Signaling pathways  
 Signaling pathways also play a role in the assembly of V-ATPase. In yeast cells, the most 
studied pathway is the Ras/cAMP/PKA (protein kinase A) pathway (Bond & Forgac, 2008). In 
the presence of glucose, Ras activation leads to the activation of adenylated cyclase followed by 
the production of cAMP. The increase in cAMP initiates PKA activity and intensifies V-ATPase 
assembly. Cytosolic acidification was shown to alter PKA and subsequently V-ATPase assembly 
(Dechant et al., 2010).  
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 In mammalian cells, the phosphoinositol-3 kinase (PI3K) pathway, AMP-activated 
protein kinase (AMPK), and mTORC pathway have been shown to play a role. The PI3K 
pathway aids in the reassembly of V-ATPase by the readdition of an active PI3K subunit (Sautin 
et al., 2005). AMPK and mTORC are crucial nutrient sensors that require the activation of the V-
ATPase Ragulator complex (C. S. Zhang et al., 2014). The V-ATPase Ragulator complex allows 
LKB1 (liver kinase B1) to dock and become phosphorylated, this leads to AMPK activation 
under glucose deprivation (C. S. Zhang et al., 2014). mTORC1 regulates cell growth by 
modulating growth factor signals and amino acid availability, it is activated in nutrient rich 
conditions. AMPK regulates energy homeostasis and is activated in nutrient poor conditions. 
Furthermore, the V-ATPase Ragulator serves to switch energy metabolism from catabolic to 
anabolic and vice versa. In a recent study, the traditional mechanism of glucose deprivation 
leading to V-ATPase disassembly was challenged by a study that reported the increase in V-
ATPase assembly after glucose-deprivation (McGuire & Forgac, 2018). This study focused on 
lysosomal renal cells and determined glucose-deprived V-ATPase disassembly activated AMPK. 
The authors concluded the increase in lysosomal V-ATPase assembly and activity under glucose-
deprived conditions was likely due to the need to change methods of energy production to non-
glycolytic processes and activate autophagy. Glucose deprivation activates autophagy, which 
necessitates the need for functional V-ATPase for the acidic requirements needed for autophagy. 
Autophagy breaks down proteins and lipids to provide energy products that can be further 








Figure 3. The Glycolytic Regulation of V-ATPase 
 













Figure 4. Nutrient signaling pathway for Glucose Stimulation 









1.1.3 V-ATPase dysregulation in neurodegenerative diseases 
 Synaptic-vesicular V-ATPase function to acidify synaptic vesicles for neurotransmitter 
uptake and create a fusion pore for the exocytosis of neurotransmitters into the synaptic cleft 
(Morel et al., 2003). These functions are vital in neurotransmission and the proper functioning of 
the brain. Although current research focuses on the function of lysosomal V-ATPase in the brain, 
further research is required to understand the impact of synaptic-vesicular V-ATPase and its 
implication in neurodegenerative diseases. 
Lysosomal V-ATPase play a crucial role in neurodegenerative diseases (Bagh et al., 
2017). Lysosomes function in intracellular digestion and function to clear debris in neurons. 
Dysfunctional neuronal lysosomes may result in either the inhibition of hydrolases by an 
aberrant increase in pH or cytotoxicity and partially digested intermediates by a more neutral pH 
(Colacurcio & Nixon, 2016). Lysosomal storage disorder (LSD) is an inheritable family of 
disorders caused by gene mutations that has been implicated in many neurodegenerative diseases 
including neurodegenerative disease in childhood and more age-related diseases such as 
Alzheimer’s and Parkinson’s disease (Fuller, Meikle, & Hopwood, 2006). LSD is characterized 
by an accumulation of macromolecules or monomeric compounds inside endosomes or 
lysosomes involved in the autophagic system. The cause of the disease can be traced to defective 








1.2 Bioenergetic substrates 
 In this thesis, various bioenergetic substrates targeting different points in cellular 
respiration were used to treat differentiated N2a cells. The following bioenergetic substrates 
were used to treat 96 h differentiated N2a cells. D-glucose is the naturally occurring form of 
glucose, the first step in glycolysis (Mergenthaler, Lindauer, Dienel, & Meisel, 2013). Pyruvate 
is the end product of glycolysis, formed by the breakdown of glucose (Rogatzki, Ferguson, 
Goodwin, & Gladden, 2015). Beta-hydroxybutyrate, known as ketone bodies, are a secondary 
source of energy formed through the breakdown of fatty acids and can enter the citric acid cycle 
(TCA) in less steps than glucose. Beta-hydroxybutyrate enters the mitochondria where it is 
converted into acetyl-coA and enters the TCA cycle (Newman & Verdin, 2014). Creatine is 
synthesized endogenously in the liver and is distributed throughout the body by blood. When 
phosphorylated, creatine-phosphate can donate high energy phosphate groups rapidly to generate 
ATP (Cooper, Naclerio, Allgrove, & Jimenez, 2012). 
 




 Glycolysis is the primary source of energy for many animals and leads to extracellular 
acidification, cytosolic alkalization, and the net production of 2 cytosolic ATP’s (Mookerjee, 
Gerencser, Nicholls, & Brand, 2017). Glycolysis is the main form of energy production in yeast 
cells, cancer cells, and astrocytes. In organisms with mitochondrial respiratory chain 
dysfunction, a shift from oxidative metabolism to glycolytic metabolism is predicted to occur as 
an adaptive mechanism to limit ROS (reactive oxygen species) production and abnormal 
signaling (Jain et al., 2016). Glucose is broken down into pyruvate in glycolysis (Rogatzki et al., 
2015). In this study, glucose was used for preliminary studies because it was the most direct 
source of energy and the first substrate in cellular respiration. We wanted to investigate whether 
glucose could regulate neuronal V-ATPase before testing other bioenergetic substrates.  
 
1.2.2. Pyruvate 
 Pyruvate, the product of glycolysis, is the last product formed in the cytosol in cellular 
respiration. Pyruvate enters the mitochondria where it becomes acetyl-CoA and enters the TCA 
cycle and then electron transport chain for oxidative phosphorylation (Rogatzki et al., 2015). 
Lactate dehydrogenase (LDH) can catalyze the conversion of lactate to pyruvate and vice versa. 
This creates the opportunity for lactate to participate in the TCA cycle. 
 
1.2.3. Ketone bodies 
 Beta hydroxybutyrate (βhb), one of three ketone bodies, are a secondary source of energy 
utilized by the body under low glucose conditions to maintain its’ bioenergetic needs. The brain 
utilizes the largest supply of energy, up to 20% of the body’s energy (Erbsloh, Bernsmeier, & 
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Hillesheim, 1958) (Newman & Verdin, 2014). Beta hydroxybutyrate (βhb) are synthesized in the 
liver and broken-down from fatty acids in the cytosol. D- βhb can then enter the mitochondria 
where it becomes acetoacetate and then acetyl-CoA, a crucial metabolic intermediate that enters 
the TCA cycle and then undergoes oxidative phosphorylation (Dedkova & Blatter, 2014). βhb is 
found predominately in blood, allowing it to easily circulate throughout the body.  
 
1.2.4. Creatine/Phosphocreatine system 
  Creatine is a popular amino acid energy supplement for athletes who need a burst of 
short-term energy (Cooper et al., 2012). Creatine can be obtained through consuming red meat or 
naturally synthesized in the liver, pancreas, and kidney. There is also evidence to point to the 
brain endogenously synthesizing creatine due to the low permeability of creatine through the 
blood brain barrier (Hanna-El-Daher & Braissant, 2016). Creatine is synthesized in the liver 
from glycine and L-arginine catalyzed by AGAT (arginine-glycine amidinotransferase) into 
Guanidinoacetate (Nouioua et al., 2013). A methionine is added and GAMT catalyzes 
Guanidinoacetate to form Creatine, where it can travel through the blood to enter the heart, 
muscle, brain, and other organs.  
Creatine-phosphate is the active energy donating form of creatine that can be formed 
through creatine kinase (CK) in the creatine-phosphate shuttle. There are two main forms of CK, 
cytosolic CK and mitochondrial CK. Mitochondrial CK lies in the intermembrane of the 
mitochondria and it phosphorylates creatine by using ATP to donate a free inorganic phosphate 
to creatine. The phosphorylated creatine, now creatine-phosphate, can then diffuse out of the 
CRT (creatine transporter) transporter back into the cytosol and donate a phosphate catalyzed by 
cytosolic CK for energy needs (Li et al., 2010). The creatine can then be shuttled back into the 
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mitochondria to become phosphorylated again. This cycle continues if there are available 
ATP/free inorganic phosphate, creatine-phosphate can even work under anaerobic conditions, 
making it an excellent source of ATP.  
 Creatine has been implicated to be regulated by AMPK activation (Ramirez Rios et al., 
2014). The creatine transporter (CRT), involved in the uptake of creatine into cells, was found to 
be stimulated by mTOR (Shojaiefard, Christie, & Lang, 2006). Additionally, AMPK is upstream 
of mTOR (Shaw et al., 2004) and can function to regulate mTOR. Previously, there was a study 
that demonstrated the inhibition of CRT by the activation of AMPK (Li et al., 2010). Taken 
together, this suggests that mTOR stimulated CRT could be inhibited by AMPK activation, 
















1.3.  Statement of Purpose 
  The Vacuolar H+ ATPase (V-ATPase) is an ATP-dependent proton pump that functions 
to acidify intracellular compartments (Parra & Kane, 1998). They are present in lysosomes, 
endosomes, plasma membranes, Golgi, vacuoles, and synaptic vesicles. The V-ATPase can 
respond to factors such as pH fluctuations, amino acid (AA) availability, intracellular ATP 
levels, and glucose availability by reversible disassembly. There are two domains that make up 
the V-ATPase, the membrane bound V0 and the cytosolic V1. During glucose deprivation in yeast 
cells, the V1 domain of the V-ATPase responds by dissociating or disassembling from the 
integral V0 to conserve intracellular ATP levels.  
  The V-ATPase have been extensively studied in yeast cells as well as recent advances in 
mammalian cells, with lysosomal V-ATPase as the focus of the studies. The mechanism and 
underlying signaling pathways for V-ATPase regulation by reversible disassembly are still not 
completely clear. This thesis seeks to elucidate the regulation of neuronal V-ATPase, an area that 
is poorly understood. Neuronal V-ATPase are concentrated in lysosomes and synaptic vesicles. 
Lysosomes are responsible for the intracellular digestion of macromolecules and in the brain, 
they function to clear debris. Functional V-ATPase are critical to acidifying lysosomes to an 
optimal pH to activate hydrolases for the subsequent digestion of debris (De Duve & Wattiaux, 
1966). Lysosomal Storage Disease (LSD), that alter the function of lysosomes, have been 
implicated in diseases such as osteoporosis, periodontal disease, osteopetrosis, and 
neurodegenerative diseases such as AD and PD (Bagh et al., 2017). Furthermore, synaptic 
vesicular V-ATPase create a proton gradient that couples the uptake of neurotransmitters, 
making it critical for synaptic vesicle filling (Moriyama et al., 1992). This process is a vital step 
preceding neurotransmission.  
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  In the first specific aim of this thesis, we sought to determine whether neuronal V-
ATPase could be regulated by glucose stimulation. The N2a cells were differentiated for 96 h 
before overnight glucose deprivation. The next day, the differentiated N2a (dN2a) cells were 
treated for 20 min with 10 mM of glucose before cell lysis. Co-immunoprecipitation was utilized 
to capture the V-ATPase complex and the eluted protein was immunoblotted. Antibodies to 
recognize the V0 and V1 domain were utilized to detect the bands. Finally, the density of the 
bands for each antibody were quantified with Image Studio Version 4.0 imaging digitizing 
software and the V0/V1 ratio was calculated and served as an index of V-ATPase assembly. 
  In the second specific aim, we sought to determine if neuronal V-ATPase could be 
regulated by other bioenergetic substrates that participated at different steps in cellular 
respiration. The bioenergetic substrates used were beta-hydroxybutyrate, sodium pyruvate, 
creatine-phosphate, and creatine-monohydrate. The same procedure described above was used to 













Chapter 2: Materials and Methods 
Materials 
The mouse neuroblastoma cell line, known as Neuro2a cells (ATCC CCL-131), and 
human pancreatic epithelioid carcinoma (PANC-1) (ATCC CRL-1469) cells gifted by the Rosa-
Molinar laboratory were from American Type Culture Collection (ATCC, Manassas, VA). The 
antibodies V-ATPase B2 (D-11) (cat# sc-166045) and V-ATPase D (E-12) (cat# sc-390384) 
were from Santa Cruz Biotechnology. The anti-ATP6V0D1 (ab202899) was purchased from 
Abcam. The horseradish peroxidase secondary antibodies, Pierce Co-immunoprecipitation kit 
(26149), Dulbecco’s Modified Eagles Medium high glucose (DMEM) (cat# 11965092), glucose-
free DMEM (cat# 11966025), and Fetal Bovine Serum (FBS) (cat# 10437028) were from 
Thermo Fisher Scientific. Concanamycin A (Cat# sc-202111) was purchased from Santa Cruz 
Biotechnology. The ATPase Activity Assay kit (MAK113-1KT) and all-trans-Retinoic acid ≥ 
98% (HPLC) (Cat# R2625) were from Sigma – Aldrich. The Mouse on Mouse Basic Kit 
(M.O.M) (BMK-2202), VECTASHIELD Antifade Mounting Medium with DAPI (H-1200), and 
Normal Goat Serum (S-1000) were purchased from Vector Laboratories. The Normal Mouse, 
Rabbit, and Donkey serums were purchased from Jackson ImmunoResearch Laboratories.  
 
Cell Culture 
The Neuro2a (N2a) and PANC-1 cells were cultured in complete growth medium 
containing Dulbecco’s Modified Eagles Medium (DMEM, high glucose) supplemented with 
10% Fetal bovine Serum (FBS) and 1% penicillin/streptomycin. The cells were maintained in a 
humidified incubator with 5% C02 at 37°C. The cells were sub-cultured every 3 days as needed 
or when the confluency reached 90%.  PANC-1 cells were gifted at passage 2. New N2a stocks 
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of frozen cells were recovered at Passage 5, 7, or 8 and sub-cultured until they reached passage 
13. Thawed N2a cells were sub-cultured twice before use to ensure optimal health. Preliminary 
studies were performed in passage 7 or 8 cells, and later studies were performed in passage 5 
cells. The N2a cells were authenticated by IDEXX BioAnalytics by STR markers to generate the 
genetic profile (Supplementary). 
 
RA-Induced Neuronal Differentiation 
The N2a cells were differentiated into a neuron-like phenotype with retinoic acid (RA). 
To investigate this neuronal model, N2a cells were seeded at a density of 1x105 to 1.5x105/mL in 
growth medium for 24 hours. The next day when cells reached 40 to 50% confluency, the 
medium was changed to differentiation medium containing 2% FBS, 20 uM all-trans-RA, and 
DMEM. The RA was prepared fresh before use from aliquoted stocks in the dark. The 
differentiation medium was replaced every 48 hours. After 96 hours, the morphological 
phenotype was validated with phase contrast imaging and western blotting with neuronal 
biomarkers such as synaptophysin, NeuN, and PSD95. The differentiated neurons were then 
treated for further studies.  
 
Antibody Validation 
Neuronal and V-ATPase antibodies, such as synaptophysin, PSD95, NeuN, V-ATPase 
V1, and V-ATPase V0, were validated in 96-hour differentiated N2a (dN2a) cells to ensure the 
specificity and sensitivity of the antibodies. Positive controls included both tissue and cell line; 
muscle tissue was used for the negative control.  
24 
 
Mouse brain tissue and PANC-1 cells were used as positive controls. PANC-1 cells are a 
human pancreatic carcinoma cell line with neuroendocrine differentiation (Gradiz, Silva, 
Carvalho, Botelho, & Mota-Pinto, 2016). The neuroendocrine differentiation in PANC-1 cells 
was validated by the expression of chromogranin A and CD56. Chromogranin A is a granin 
protein present in the secretory granules of neuroendocrine cells and is widely used as a marker 
for neuroendocrine tumors (Theurl et al., 2010). CD56, or neural-cell adhesion molecule 
(NCAM), is a glycoprotein that regulates neuron to neuron interactions and promotes neurite 
outgrowth (Doherty & Walsh, 1996; Kolkova, Novitskaya, Pedersen, Berezin, & Bock, 2000). 
Due to these properties, PANC-1 cells were chosen as a positive control.  
The selection of the appropriate negative control for both neuronal and V-ATPase 
antibodies was challenging since V-ATPase is known to be ubiquitous and present in 
intracellular organelles such as lysosomes. Previous studies have reported the controversial 
presence of lysosomes in skeletal muscle, it was found to have a low activity of acid hydrolases, 
promoting the idea that skeletal muscle used lysosomes from macrophages and connective tissue 
cells. A study investigating the contribution of lysosomes from various sources in skeletal 
muscle tissues concluded muscle fibers do not have secretory or excretory functions; therefore 
there was no need for an advanced lysosomal vacuolar system to be in place (Canonico & Bird, 
1970). Due to this, mouse skeletal muscle, specifically the latissimus dorsi, was used as a 
negative control for neuronal antibodies and tested for V-ATPase antibodies. 
Differentiated N2a cells were grown, differentiated, and harvested according to 
previously stated methods. Passage 4 PANC-1 cells were grown until a confluency of 80% was 
reached and incubated in RIPA buffer with protein phosphatase inhibitor for 5 min before 
harvesting. The cells were centrifuged at 12,000 x g for 10 min and the supernatant was 
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collected. Mouse Brain tissue and skeletal muscle in RIPA buffer supplemented with protease 
and phosphatase inhibitor was homogenized with a homogenizer and placed on ice for 30 
minutes. The tissue extracts were then centrifuged at 10,000 x g for 10 min and the supernatant 
was collected. A bicinchoninic acid assay was performed to determine the protein concentration. 
Western blotting steps follow the procedures stated below and was performed with 20 µL of 
brain tissue loaded at a concentration of 0.7µg/µL and 1 µg/µL of skeletal muscle and cell lysate.  
Table 2. Antibodies for Immunoblots and Co-immunoprecipitation 




















1:5000 Neuronal Marker for validating 
model 
V-ATPase B2 
(D-11) – V1 
Mouse Ab 
Santa Cruz, cat# sc-
166045 
IP: 1:20   
WB: 1:1000 
Antibody used for capturing V-
ATPase complex 
V-ATPase D 
(E-12) – V1 
Mouse Ab 
Santa Cruz, cat# sc-
390384 
1:1000 Detected the V1 domain by WB 
V-ATPase d1 – 
V0 
Rabbit Ab 



















The 96-hour differentiated N2a (dN2a) cells was treated with glucose-deprived medium 
(2% FBS, glucose-free DMEM) overnight. The non-glucose-deprived (NGD) condition was 
treated with 2% FBS and high glucose DMEM. After overnight glucose-deprivation, dN2A cells 
were treated with vehicle treatment of sterile ddH2O or ethanol and substrates such as 10 mM 
glucose (D-(+)-Glucose, Sigma G8720), 3-Hydroxybutyric acid (Sigma, 166898), sodium 
pyruvate (Sigma, P2256), creatine phosphate (Sigma, CRPHO-Ro Roche), or creatine 
monohydrate (Sigma, C3630) for 20 minutes prior to collection. Cells were washed with ice-cold 
Phosphate Buffered Saline (1x PBS, pH 7.4) and collected on ice with IP Lysis and protein 
phosphatase inhibitor for 5 minutes. Then the cells were centrifuged 12,000 x g for 10 minutes to 
remove insoluble material and the supernatant was collected. Further experiments were 
conducted on the cell lysates or stored in -80°C for later use.   
 
Immunoblotting 
 Differentiated N2a cells were washed three times with ice-cold phosphate-buffered saline 
(PBS) (pH 7.4, Thermo Fisher Scientific) before lysing with IP Lysis (Pierce Co-
immunoprecipitation kit, Thermo Fisher Scientific) containing protease and phosphatase 
inhibitors (Thermo Fisher Scientific) for 5-10 minutes on ice. Whole cell lysate was centrifuged 
at 12,000 x g for 10 min. The supernatant was collected and Bicinchoninic acid assay 
(BCA)(Thermo Fisher Scientific) was performed to determine the levels of protein 
concentration. Equal amounts of protein concentration were calculated and diluted in Laemmli 
4x sample buffer (Bio-RAD) with 2-mercaptoethanal (Bio-RAD) before being boiled at 95°C for 
5 minutes. Equal amounts of protein were loaded into each lane on the 10% sodium dodecyl 
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sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). After SDS-PAGE, the gel was 
transferred onto a methanol-activated 0.2 µm pore-sized PVDF membrane (Bio-Rad). Then the 
membrane was blocked with 2% of non-fat milk in 1x TBS for at least 40 minutes at room 
temperature on a rocker. The primary antibody was incubated overnight at 4°C. The next day the 
membranes were washed three times with 1x TBST for 8 minutes each before detection with 
horseradish peroxidase (HRP) conjugated secondary antibody for 1-2 hours. The membrane was 
washed again before adding the enhanced chemiluminescence (ECL) reagent (Bio-Rad) for the 
appropriate amount of time between 5-20 minutes. The membrane was then scanned, and the 
bands were quantified with Image Studio Version 4.0 imaging digitizing software. 
The band density was quantified with the same size of rectangle in each membrane. 
 
V-ATPase Assembly – Co-immunoprecipitation  
The N2a cells were differentiated and treated according to the methods described 
previously. The cells were collected with IP-Lysis buffer, provided by the Pierce co-
immunoprecipitation kit, and protein phosphatase inhibitor. The supernatant was collected after 
centrifugation and a bicinchoninic acid (BCA) protein assay (Pierce) was used to determine the 
protein concentration in the cell lysate. The V-ATPase B2(V1)-specific Mab was used for the 
immunoprecipitation of the V-ATPase complex. Equal amounts of pre-cleared cell lysate were 
loaded into each antibody immobilized spin column (V-ATPase B2(V1) monoclonal antibody 
and control Ms IgG antibody) and incubated overnight on a rotator at 4°C. The next day, the free 
V1 domains and assembled V-ATPase complex were eluted from the antibody-coupled spin 
columns. The eluted samples collected were diluted in 4x Laemmli sample buffer (Bio-Rad, CA) 
with 2-mercaptoethanol (Bio-Rad, CA) and heated at 95°C for 5 minutes. Equal amounts of 
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protein were separated by SDS-PAGE (10% acrylamide gels) and transferred onto 0.2 µm pore-
sized PVDF membranes (Bio-Rad, CA). The membrane was blocked with 2% non-fat milk in 
TBST for at least 40 minutes at room temperature and incubated with anti-V-ATPase V0 1:5000 
overnight at 4°C and then horseradish peroxidase secondary antibody for 1 hour the following 
day. After scanning, the membrane was stripped for 5 minutes and washed before re-blocking the 
membrane. The same procedure as previously described was repeated with the incubation of 
anti-V-ATPase V1 1:1000 overnight at 4°C. The membrane was scanned using C-Digit Blot 
Scanner (LI-COR, Lincoln, NE) and the intensity of protein bands were quantified with Image 
Studio Version 4.0 imaging digitizing software. The ratio of the protein band densities for the 
anti-V-ATPase V0/V1 antibodies were used to calculate V-ATPase assembly. The conditions 
were normalized to the V0/V1 ratio of the control condition for comparison. 
 
Statistical Analysis 
GraphPad Prism 6 (GraphPad Software, La Jolla, CA, USA) was used to conduct 
statistical analyses. The data was analyzed with a one-way analysis of variance (ANOVA) and 
Tukey’s post hoc multiple comparisons of mean±sd. Pyruvate and Beta-hydroxybutyrate treated 









Chapter 3: Results 
1. Biochemical Validation of Neuronal and V-ATPase Antibodies in Differentiated 
Neuro2a cells 
Neuronal and V-ATPase antibodies were validated to ensure their specificity and 
sensitivity in differentiated N2a (dN2a) cells. Two positive controls and a negative control were 
tested with the dN2a cells. Mouse brain tissue was homogenized and served as a positive control. 
PANC-1 is a human pancreatic carcinoma cell line with neuroendocrine differentiation (Gradiz 
et al., 2016) and served as a positive control. Since V-ATPase is known to be present in 
intracellular organelles and is ubiquitous, mouse skeletal muscle, specifically the latissimus 
dorsi, was thought to be an appropriate negative control for neuronal and V-ATPase antibodies 
due to its’ controversial presence of lysosomes (Canonico & Bird, 1970). The results 
demonstrate the antibodies were positively characterized in brain tissue, dN2a, and in PANC-1 
cells, except for synaptophysin, which is congruent with a previous study (Gradiz et al., 2016). 
As expected, skeletal muscle tissue did not detect neuronal markers but detected V-ATPase 
antibodies. However, the V-ATPase antibodies were detected with lower levels of specificity. 
This indicates skeletal muscle was an appropriate negative control for neuronal antibodies but 











Figure 6. Antibody Validation for Differentiated Neuro2a cells.  
Neuronal and V-ATPase antibodies were validated in dN2a cells with brain tissue and in PANC-
1 cells used as positive controls and mouse latissimus dorsi muscle used as a negative control. 
Antibodies were successfully detected in brain tissue and PANC-1 cells, except for 
synaptophysin in PANC-1 cells. Latissimus dorsi muscle was a successful negative control for 
neuronal antibodies but not for V-ATPase antibodies. V-ATPase antibodies were detected in 
latissimus dorsi muscle, albeit with lower sensitivity, which suggests latissimus dorsi muscle was 
not the appropriate negative control.  
 
2. Morphological and Biochemical Characterization of Neuronal Phenotype of RA-
differentiated N2a cells 
To investigate the effects of various substrates on neuronal V-ATPase, N2a cells were 
differentiated into a neuronal phenotype by a combination of all-trans-retinoic acid (RA) and 
serum deprivation according to previous studies (Mao et al., 2000; Tremblay et al., 2010; Namsi 
et al., 2018). The N2a cells were seeded at a density of 1.5x105/mL and allowed to proliferate for 
24 hours in growth medium containing 10% FBS, 1% antibiotics, and DMEM. The N2a cells 
were then differentiated for 96 hours in 20 uM RA in 2% FBS and DMEM. The differentiated 
N2a (dN2a) phenotype was examined morphologically and biochemically in a time-dependent 
manner at 0 hours, 48 hours, and 96 hours. Validated neuronal markers such as Synaptophysin, 
NeuN, and PSD95 were utilized to validate the neuronal phenotype biochemically through 
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immunoblotting. Synaptophysin is a ubiquitous synaptic vesicle membrane protein involved in 
the formation of synapse, regulation of neurotransmitter release, and the production of synaptic 
vesicles (Wheeler et al., 2002; Eshkind et al., 1995; J Alder et al., 1995; Janz R et al., 1999). 
NeuN protein is expressed in nervous system tissues, specifically cell nuclei, and has been used 
as a neuron-specific marker for studying stem cell differentiation (Hess et al., 2002; Verdiev Bl 
et al., 2009). PSD95, post-synaptic density protein, is a scaffolding protein present in mature 
synapses (Yoshii A et al., 2011). V-ATPase B2 (V1), an isoform expressed in the brain, was also 
used as a marker for the V1 domain of neuronal V-ATPase (C. Pietrement et al., 2006; S. T. 
Boesch et al., 2003). A time-dependent increase in optical density was observed in immunoblots 
probed with synaptophysin, NeuN, PSD95, and V-ATPase B2 (V1) shown in (Fig 7b), indicating 
a progressive increase in neuronal phenotype. Western blots for NeuN and V-ATPase B2 (V1) 
demonstrated significant protein expression levels as early as 48 hours. Synaptophysin and 
PSD95 did not show significant protein expression levels until 96 hours of differentiation. The 
morphological phenotype was validated through inverted microscope imaging. Progressive 
neuron-like processes were observed in a time-dependent manner with RA stimulation (Fig 7a). 
In summary, the morphological and biochemical results confirm the neuronal phenotype of the 
96 h – differentiated N2a cells and validate dN2a cells as a suitable in-vitro neuronal model for 

































Figure 7. Morphological and Biochemical Characterization of Differentiated N2a cells. (a) 
Morphological phenotype validation of N2a cells differentiated by 20 µM RA and 2% FBS. The 
Zeiss inverted microscope with 20X magnification confirmed the progressive time-dependent 
increase in neuronal phenotype from 0 h, 48 h, to 96 h of differentiated N2a cells. The red scale 
bar represents a length of 50 µm. (b) Western blots of the neuronal markers NeuN, 
Synaptophysin, and PSD95 confirm the time-dependent increase in neuronal phenotype from 0h 
to 96 h. V-ATPase antibody for B2 (V1) was also used to confirm the time-dependent increase in 
V-ATPase. Immunoblotting results were normalized to the undifferentiated 0 h condition and 
compared using a one-way ANOVA with Tukey’s Post hoc Test. *p<0.05, **p<0.01. Data 
represent the group mean ± SD. N=2 for NeuN, N=3 for all other antibodies. 
 
3. V0/V1 Protein Expression levels were not altered by glucose treatment 
 Since co-immunoprecipitation of the V-ATPase complex and immunoblotting will be 
used to determine V-ATPase assembly by calculating the V0/V1 ratio, the protein expression of 
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V0V1 was determined in treated cell lysate by measuring the average relative densities of the 
bands. First, 96 h dN2a were glucose-deprived overnight in glucose-free DMEM and 2% FBS. 
Control dN2a cells continued its maintenance in fresh medium composed of DMEM and 2% 
FBS. The next day, the glucose-stimulated condition was treated with 10mM or 25mM of D-
Glucose or vehicle (ddH2O) for 15-20 min before cell lysis. Next, equal amounts of treated cell 
lysate was used in immunoblotting. The membrane was probed with V-ATPase d1 (V0) and then 
V-ATPase D (V1) after stripping to measure the total protein expression of V0 and V1 in treated 
cell lysates. The results in Fig 8 demonstrate there is no significant difference in the average 
relative density of V0 or V1 between treated cells – non-glucose-deprived (NGD), glucose-
deprived (dep), and 10mM (G10) or 25mM (G25) glucose-stimulated cells. This result indicates 
that treatment with bioenergetic substrates does not lead to an alteration in protein expression. 
Therefore, any difference in measured V-ATPase Assembly V0/V1 through co-
immunoprecipitation would be attributed to the substrate treatment and not due to the alteration 














Fig 8. V0V1 protein expression levels in cell lysate were not altered by glucose treatment. 
Immunoblots of glucose-treated (non-glucose-deprived (NGD), glucose deprived (dep), 10mM 
glucose (G10), 25mM glucose (G25)) cell lysate was loaded in equal amounts and detected with 
V-ATPase d1 (V0) and V-ATPase D (V1) to measure the average relative density of V0 and V1. 
The total average relative densities of V0 and V1 were not significantly altered between the 
treated cell lysates, indicating treatment did not alter total protein expression. Therefore, 
differences in V0/V1 assembly levels between the treated groups from co-immunoprecipitation 
studies are attributed to the treatment and not an alteration in total protein expression. 
Immunoblotting results were normalized to the control NGD condition and compared using a 
one-way ANOVA with Tukey’s hoc test. Data represent the group mean± SD. N=4 per group. 
 
 
4. V-ATPase Assembly was not significantly altered by glucose stimulation 
 Glucose is a known regulator of V-ATPase V0/V1 assembly in yeast and mammalian cells 
(MP Collins et al., 2018; Chan et al., 2016). Glucose stimulation in these cells lead to an increase 
in V-ATPase V0/V1 assembly whereas deprivation leaves the V0/V1 disassembled. The 
mechanism of regulation for neuronal V-ATPase is unclear. To determine whether neuronal V-
ATPase is regulated by glucose, the validated 96 h dN2a cells were used as model of 
investigation. The 96-hour differentiated N2a cells were deprived of glucose overnight in 2% of 
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FBS and glucose-free DMEM. The control dN2a cells continued its maintenance in fresh 
medium composed of DMEM and 2% FBS. The next day, the cells were stimulated with 10 mM 
of glucose or vehicle alone for 20 min before collection. Equal amounts of cell lysate were co-
immunoprecipitated with V-ATPase B2 (V1) antibody and assembled V-ATPase complexes and 
free V1 were eluted. The eluate was diluted in Llaemmli sample buffer and equal volumes were 
loaded in a 10% SDS gel for western blotting. As shown in Fig 9a, glucose stimulation induced a 
significant increase in V0/V1 assembly compared with glucose deprived cells in preliminary 
studies. There was no significant difference between control non-glucose-deprived (NGD cells 
with either glucose stimulated or glucose-deprived cells. Further analysis with an increase in 
sample size and duplicates or triplicates in each treatment was conducted (Fig 9b). These results 
demonstrate there was no significant difference in V-ATPase assembly with glucose stimulation 
and glucose-deprivation across 5 different samples. One run (Fig 9c) out of the 5 samples 
indicated that stimulation with 10mM of glucose significantly induced V-ATPase disassembly as 
compared with the glucose-deprived cells and that stimulation with 25mM of glucose 

















Fig 9. Neuronal V-ATPase regulation by glucose. 96h dN2a cells were glucose-deprived 
overnight before treatment with 10mM or 25mM of D-Glucose or vehicle alone for 20 min. 
Equal amounts of cell lysate were co-immunoprecipitated and protein expression was assessed 
using immunoblotting. V-ATPase d1 (V0) and then V-ATPase D (V1) antibody was detected. 
The density of the bands was quantified to calculate the V0/ V1 ratio to measure V-ATPase 
assembly. (a) Preliminary studies demonstrated Glucose-stimulated (G10) cells had significantly 
more assembled V-ATPase compared to glucose-deprived (Dep) cells, but there was no 
difference compared to control non-glucose-deprived (NGD) cells. Glucose-deprived cells were 
also not significantly different from control NGD cells. *p=0.0443, N=3 (b) Further investigation 
demonstrated there was no significant difference in V-ATPase assembly between the treatment 
groups. ns p=0.1253, N=5. (c) One experiment demonstrated a significant decrease in V-ATPase 
assembly from vehicle treated glucose-deprived cells and 10mM of glucose, as well as a 
significant increase from 10mM to 25mM of glucose treatment. **p=0.0034. Immunoblotting 
results were normalized to the control non-glucose-deprived (NGD) condition in each group and 
compared using one-way ANOVA with Tukey's Post hoc Test. *p<0.05, **p<0.01. Data 
represent the group mean± SD.  
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5. V-ATPase Assembly was not significantly altered by bioenergetic substrates  
 Next, various substrates were used to test the effects on V-ATPase assembly after the 
initial studies with glucose-stimulated and glucose-deprived cells. The substrates used were beta-
hydroxybutyrate (βhb), pyruvate (pyr), creatine-phosphate (CrP), and creatine-monohydrate 
(CrMH). These substrates were used as they represent different entry points in energy 
metabolism. Previous research indicated yeast cells responded best to rapidly metabolizable 
substrates such as glucose, fructose, and mannose. The 96-h dN2a cells were deprived of glucose 
overnight in 2% FBS and glucose-free DMEM and regular DMEM for control cells. The next 
day, cells were stimulated with either 10 mM D-Glucose, βhb, sodium pyruvate, creatine-
phosphate, creatine-monohydrate, or vehicle alone for 20 min before cell lysate collection. As 
shown in Fig 10, the bioenergetic substrates had no significant effect on V-ATPase assembly as 




















Fig 10. Neuronal V-ATPase regulation by other bioenergetic substrates. 96h dN2a cells were 
glucose-deprived overnight and then treated with 10 mM of each bioenergetic substrate or 
vehicle alone the next day for 20 min. Equal amounts of cell lysate were co-immunoprecipitated 
and equal volumes of the captured eluate was assessed for the protein expression of V-ATPase 
d1 (V0) and then V-ATPase D (V1) using immunoblotting. The density of the bands was 
quantified to calculate the V0/ V1 ratio to determine V-ATPase assembly. (a) Mitochondrial 
substrates, βhb and pyruvate, demonstrated no significant difference in V-ATPase assembly 
compared with their respective vehicle treated glucose-deprived cells. Dep vs Pyr, N=3. Dep vs 
βhb, N=4. (b) Creatine-phosphate and creatine-monohydrate also demonstrated no significant 
difference in V-ATPase assembly compared with the vehicle treated glucose-deprived cells. 
N=3. Immunoblotting results were normalized to the vehicle treated glucose-deprived condition 
in each group and compared using a one-way ANOVA with Tukey's Post hoc Test. *p<0.05, 
**p<0.01. A students T-test was used to compare βhb to the vehicle treated (ethanol) glucose-
deprived condition and pyruvate to the vehicle treated (ddH2O) glucose-deprived condition. Data 









Chapter 4: Discussion 
 
 
 The purpose of this thesis was to determine whether neuronal V-ATPase is regulated by 
glucose and if so, to investigate the effect of other bioenergetic substrates on V-ATPase 
assembly. This discussion will address the results, potential pitfalls, and discrepancies compared 
with previous studies, and point to future directions.  
Variance 
 Initial studies were conducted in N2a cells thawed at passage 7 or 8, whereas later studies 
were performed in N2a cells thawed at passage 5. Initial studies demonstrated that some 
bioenergetic substrates, such as glucose, significantly increased neuronal V-ATPase assembly, 
which contradicts later studies that showed no significant change in V-ATPase assembly. Several 
western blots from initial studies were repeated with more stringent conditions after later studies. 
There were a few repeated results that did not demonstrate the same significant results as 
previously. The cause of this discrepancy between initial and later studies is unknown. The 
variance between the bioenergetic substrates observed in initial data could be attributed to a low 
sample size and replicates, leading to low statistical power, or to cell health. The use of a higher 
number of samples, replicates, and lower passage of cells in later studies eliminated the variance 
observed in initial studies.  
Antibody Validation 
 Neuronal and V-ATPase antibodies were validated to determine their specificity and 
sensitivity in dN2a cells. As expected, the antibodies were successfully detected in brain tissue. 
PANC-1 cells are a human pancreatic carcinoma cell line with neuroendocrine differentiation 
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that served as a positive control. The PANC-1 cells detected the neuronal and V-ATPase 
antibodies except for synaptophysin. This negative detection of synaptophysin is congruent with 
a previous study (Gradiz et al., 2016). Although, the negative detection of synaptophysin is likely 
due to the undifferentiated state of the PANC-1 cells. Synaptophysin detection was previously 
reported (Egawa, Maillet, VanDamme, De Greve, & Kloppel, 1996) to be enhanced in 
differentiated PANC-1 cells. In future experiments, synaptophysin could be characterized in 
differentiated PANC-1 cells to observe its expression. For the negative control, mouse latissimus 
dorsi muscle was used as a negative control for the neuronal antibodies and was unsuccessful for 
V-ATPase antibodies. V-ATPase is ubiquitous and present in most intracellular organelles such 
as lysosomes. Since the presence of lysosomes are controversial in skeletal muscle (Canonico & 
Bird, 1970), it was chosen as a negative control. As expected, neuronal antibodies were not 
detected in skeletal muscle tissue, but V-ATPase antibodies were detected. Although, the V-
ATPase antibodies were detected with lower levels of sensitivity. Thus, skeletal muscle tissue 
was not the appropriate negative control for V-ATPase markers. The neuronal and V-ATPase 
antibodies were detected in dN2a cells, except NeuN expressed a lower sensitivity. The 
validation of the antibodies demonstrates the specificity of the neuronal antibodies and a varying 
level of specificity for the V-ATPase antibodies, which was expected due to the ubiquitous 
nature of V-ATPase.  
Morphological and Biochemical Characterization of dN2a cells 
 Differentiated N2a (dN2a) cells were characterized morphologically and biochemically. 
In Fig 7a, microscopy images of N2a cells observed at 0 hr, 48 hr, and 96 hrs after 
differentiation demonstrate an increased growth in neural processes, indicating a neuronal 
phenotype. Next, the validated neuronal and V-ATPase antibodies were utilized to characterize 
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the differentiated N2a cells. In Fig 7b, the expression of the neuronal markers was shown to be 
significantly increased in a time-dependent manner in dN2a cells. The morphological images and 
significant time-dependent enhancement of validated neuronal markers confirms the neuronal 
phenotype of 96 h differentiated N2a cells.  
Protein Expression levels of V0V1 in Cell Lysate 
 To ensure protein expression is not upregulated after treatment with bioenergetic 
substrates such as glucose, immunoblotting was performed to detect the average density of V-
ATPase V0 and V1 antibodies on treated cell lysates. The results (Fig 8) demonstrated there was 
no significant difference in average relative density between the treatment groups for both the V-
ATPase V0 and V1 antibodies. Beta-tubulin was used as a loading control. This result suggests 
any difference observed in further studies between the treatment groups is attributed to changes 
in V-ATPase assembly and not to changes in V0 and V1 expression. 
Neuronal V-ATPase Regulation by Glucose after chronic glucose-deprivation 
 V-ATPase assembly in glucose-treated cells was measured through the co-
immunoprecipitation of free V1 and assembled V-ATPase complexes and immunoblotting of the 
captured eluate to calculate the ratio of the V0 and V1 antibodies. Excess V1 is captured along 
with the V-ATPase complex with the use of a V1 antibody. The low variability of the average 
density of total V0 and V1 in cell lysate and the fact that the V0/V1 ratio is used for the index of 
V-ATPase assembly corrects for the excess V1.  
The experimental design was modeled after a previous study conducted in mammalian 
cells (Sautin et al., 2005), specifically HK-2 (human proximal tubular cells) and LLC-PK 
(porcine renal epithelial cells). The renal epithelial cells were maintained in medium containing 
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10% FBS and 5.5mM of glucose, then chronically deprived of glucose in glucose-free DMEM 
overnight (16 h) and stimulated the next day with 10mM of glucose for 15 min. The V-ATPase 
complex was captured with a V1 antibody in equal amounts of cell lysate and immunodetection 
with a V0 and V1 antibody was performed to calculate the ratio of V-ATPase assembly. This 
study reported overnight glucose-deprivation leads to significant V-ATPase disassembly 
compared with cells maintained in complete medium. Furthermore, cells stimulated with 10mM 
of glucose for 15 min rescued and increased V-ATPase assembly. The absence of a control 
condition with 5.5mM glucose to restore glucose levels after overnight deprivation makes it 
difficult to accurately compare whether the absence of glucose stimulation and 25mM glucose 
significantly impacted V-ATPase assembly. Due to these results, we expected to observe the 
disassembly of V-ATPase after chronic overnight glucose-deprivation and the restoration of V-
ATPase assembly after acute glucose stimulation. 
A more recent study investigating the effect of glucose on V-ATPase assembly in 
mammalian cells after acute glucose-deprivation demonstrated opposing results (McGuire & 
Forgac, 2018). In this study, HEK293T cells were maintained in serum-free DMEM with 5mM 
of glucose. The cells were then treated with fresh medium containing either glucose-free DMEM 
(10 min), 5mM glucose (1 h), 25mM glucose (1 h), or 0mM glucose (10 min) and then 5mM 
glucose (10 min). In contrast with the previous study, their results indicated acute glucose-
deprivation (10 min) significantly increased V-ATPase assembly compared with cells maintained 
in physiological 5mM of glucose. In agreement with the previous study, cells stimulated with 
25mM of glucose also had significantly increased V-ATPase assembly compared with the 
physiological condition. It is not clear why the cells were only deprived of glucose for 10 min 
when the other groups were treated for 1 h. Furthermore, the increase in V-ATPase assembly 
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observed after 10 min of glucose-deprivation may disappear or even decrease if lengthened to 1 
h, possibly as a mechanism to preserve ATPs. Therefore, it is not known whether V-ATPase 
assembly was truly increased due to the lack of controls.  
Consistent with literature, preliminary studies in passage 7 and 8 N2a cells indicated 
10mM of glucose stimulation (G10) significantly increased neuronal V-ATPase assembly 
compared with glucose-deprived cells (Dep), although vehicle-treated non-glucose-deprived 
(NGD) cells were not significantly different compared with glucose-deprived cells (Fig 9a). The 
absence of change in V-ATPase assembly after chronic overnight glucose-deprivation suggests 
the activation of compensatory mechanisms that allow basal levels of V-ATPase assembly to 
maintain homeostatic conditions. Congruent with yeast and mammalian cells, the preliminary 
results suggest that V-ATPase assembly in neuronal cells respond to glucose fluctuations. This 
increase in V-ATPase assembly could be attributed to cytosolic alkalization and ATP production 
by glycolysis, rabconnectin binding, glycolytic enzymes, or a combination of these factors. This 
result indicates glucose plays a role in V-ATPase assembly and this regulatory mechanism is 
conserved in neuronal cells.  
Further analysis of the effects of glucose on neuronal V-ATPase assembly was conducted 
under more stringent conditions, with an increased sample size and duplicates or triplicates of 
each treatment group included. Also, the experiments were performed in passage 5 N2a cells, a 
lower passage compared with preliminary studies. The overall results (Fig 9b) demonstrated 
there was no significant difference in V-ATPase assembly among the treatment groups. Three 
out of five experiments from different cell lysate samples demonstrated no significant changes in 
V-ATPase assembly among the treatment groups. One sample indicated significance, but the 
Tukey’s post hoc test did not reveal which two groups were significantly different. Finally, one 
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sample (Fig 9c) demonstrated dN2a cells treated with 10mM of glucose significantly decreased 
V-ATPase assembly when compared with vehicle-treated glucose-deprived cells. Additionally, 
cells treated with 25mM of glucose significantly increased V-ATPase assembly compared with 
cells treated with 10mM of glucose. Congruent with preliminary results, the vehicle-treated non-
glucose-deprived cells (maintained in medium containing 25mM of glucose) was not 
significantly different compared with glucose-deprived cells. This particular result demonstrated 
overnight glucose-deprivation does not lead to significant changes in V-ATPase assembly. Also, 
stimulation with 10mM of glucose induces V-ATPase disassembly and the addition of a higher 
concentration of glucose (25mM) reverses the disassembly and leads to an increase in V-ATPase 
assembly. The reason for the disassembly observed with the addition of 10mM of glucose 
compared with the glucose-deprived condition could be attributed to the cells being maintained 
and conditioned to 25mM of glucose prior to overnight deprivation. Thus, stimulation with a 
lower concentration of glucose may not allow V-ATPase assembly to be restored or exceed 
physiological levels. Compensatory mechanisms could be responsible, but more investigation is 
needed since the results were not reproducible.  
Taken together, further analyses demonstrated glucose stimulation had no significant 
effect on neuronal V-ATPase assembly in chronically glucose-deprived cells and does not 
support preliminary results. This could be attributed to increased sample sizes and replications as 
well as a lower passage of N2a cells. The results also indicate neuronal dN2a cells may respond 
to glucose stimulation or chronic glucose-deprivation differently than mammalian and yeast cells 





Neuronal V-ATPase regulation by other bioenergetic substrates after chronic glucose-
deprivation 
 Next, we tested the efficacy of other bioenergetic substrates on V-ATPase assembly. We 
sought to examine whether substrates that enter during later steps in cellular respiration could 
also influence neuronal V-ATPase assembly. The bioenergetic substrates tested were sodium 
pyruvate, beta-hydroxybutyrate (βhb), creatine-phosphate (CrP), and creatine-monohydrate 
(CrMH). Pyruvate, the end product of glycolysis, enters the mitochondrial matrix from the 
cytosol. There it is converted to acetyl-coA by pyruvate dehydrogenase (PDH) and enters the 
Citric Acid Cycle (TCA cycle). Beta-hydroxybutyrate (βhb), one of three ketone bodies, is a 
secondary source utilized by the body under low glucose conditions to maintain its’ bioenergetic 
needs. Fatty acids are broken down by the liver during ketosis to produce D- βhb. It enters the 
mitochondria where it is converted into acetoacetate and then acetyl-coA, thereby entering the 
TCA cycle. Pyruvate and βhb are both involved in oxidative phosphorylation in the mitochondria 
and produce 38 ATP’s (Gautheron, 1984), significantly more ATP’s than glycolysis. Creatine is 
an amino acid that becomes phosphorylated by mitochondrial creatine kinase (CK) in the 
intermembrane of the mitochondria to become Cr-P, an energy storing compound. Cr-P shuttles 
into the cytosol where it can readily donate a high-energy phosphate by cytosolic CK to form 
ATP, then it reenters the mitochondria to become phosphorylated and the cycle continues. The 
rapid production of ATP makes creatine a common supplement for athletes that require short 
bursts of intense energy, with creatine-monohydrate (Cr-MH) as the most popular form. Cr-MH 
is indistinguishable from creatine and must enter the mitochondria to convert into the energy 
storing compound creatine phosphate. 
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 Surprisingly, the results indicated the addition of 10mM of bioenergetic substrates did not 
significantly increase V-ATPase assembly compared with the chronically glucose-deprived 
condition. Therefore, bioenergetic substrates have no effect on neuronal V-ATPase assembly. 
The discrepancy compared with previous studies is unknown. We reason it could be attributed to 
nonoptimal conditions such as length of glucose-deprivation, substrate concentration, or 
incubation time of the substrate treatment. 
Future Directions 
To improve future experiments, potential pitfalls will be addressed in this section. The V-
ATPase has been studied extensively in yeast and some mammalian cells, but there is a lack of 
research on neuronal V-ATPase. To properly investigate neuronal V-ATPase assembly, further 
experiments must be conducted to optimize experimental conditions and to determine the cellular 
response of neuronal V-ATPase. 
In contrast to previous studies, the results of this study indicate glucose and other 
bioenergetic substrates do not induce a significant change in V-ATPase assembly. Studies 
investigating V-ATPase assembly in yeast cells typically deprived cells of glucose for 20-30 
min; whereas mammalian cells were subjected to glucose-deprivation from acute deprivation for 
10 min to overnight deprivation for up to 16 h. Future investigations could measure neuronal V-
ATPase assembly at various time points after glucose deprivation to determine the optimal 
length of incubation. Another way to accomplish this would be to experimentally determine the 
length of time it takes for significant V-ATPase disassembly to occur by measuring V-ATPase 
activity levels. This would allow the optimization of incubation time for glucose-deprivation. 
Glucose and bioenergetic substrate concentrations exceeding the physiological level of 25mM 
could also be tested. A pitfall of the current study is the exclusion of a glucose stimulation group 
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with an elevated concentration relative to the physiological concentration of 25mM. This could 
also be corrected by conditioning dN2a cells to a lower concentration of glucose prior to 
bioenergetic substrate stimulation. Furthermore, the experiments could be replicated in other 






















Chapter 5: Conclusion 
 This study sought to investigate the effect of bioenergetic status on neuronal V-ATPase 
assembly. The results demonstrate bioenergetic substrates such as glucose, pyruvate, beta-
hydroxybutyrate, creatine phosphate, and creatine monohydrate did not have a significant effect 
on neuronal V-ATPase assembly following chronic glucose-deprivation. This is not congruent 
with previous studies carried out in yeast and mammalian cells that provide overwhelming 
evidence supporting the regulation of V-ATPase assembly by glucose. Further investigations 
need to be conducted to optimize experimental conditions for neuronal V-ATPase studies. These 
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SFigure 2. Morphological and Biochemical Characterization of Neuronal Phenotype of RA-

















































































































































































































































































N2a Cell Authentication 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
84 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
85 
 
 
